ARID1A Mutation May Define an Immunologically Active Subgroup in Patients with Microsatellite Stable Colorectal Cancer

Overview of attention for article published in Clinical Cancer Research, January 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (83rd percentile)
Above-average Attention Score compared to outputs of the same age and source (62nd percentile)

Mentioned by

twitter: 25 X users

Citations

dimensions_citation: 34 Dimensions

Readers on

mendeley: 29 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 26 X posts from 25 X users, with an upper bound of 111,559 followers.

RT @BenWestphalen: Out in @CCR_AACR by @skopetz & team: ARID1A mutation may define an immunologically active subgroup in patients with mic…

26 Jul 2021

Reply Repost Favourite

RT @BenWestphalen: Out in @CCR_AACR by @skopetz & team: ARID1A mutation may define an immunologically active subgroup in patients with mic…

25 Jul 2021

Reply Repost Favourite

RT @BenWestphalen: Out in @CCR_AACR by @skopetz & team: ARID1A mutation may define an immunologically active subgroup in patients with mic…

25 Jul 2021

Reply Repost Favourite

COLORECTAL: retrospective biomarker studies of human samples suggest that ARID1A mutation may be associated with increased immunogenicity in microsatellite stable disease; the underlying mechanism is not clear. https://t.co/wZoAotwmeE

01 Apr 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 22 additional X posts.